Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic ReviewPHARMACEUTICALSIF4.82024-10-030OAAI
Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in RomaniaPHARMACEUTICALSIF4.82024-09-234OAAI
Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice StudyBIOMEDICINESIF3.92023-09-041OAAI
Evaluating the Adipose Tissue Depth as a Predictor Factor for Gestational Diabetes in Later Pregnancy-A Systematic ReviewBIOMEDICINESIF3.92023-05-226OAAI
The Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists in the Standard of Care Treatment of Type 2 Diabetes MellitusLIFE-BASELIF3.42023-03-204OAAI
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19BIOMEDICINESIF3.92022-10-1911OAAI
The Outcome of Surgical Treatment for the Neuropathic Diabetic Foot Lesions-A Single-Center StudyLIFE-BASELIF3.42022-07-293OAAI